Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06065449 · ClinicalTrials.gov registry record · Phase 3
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
A Phase 3 study of Bone Metastases, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 220
- Enrollment target
- 1
- Study location
NCT06065449: Recruiting Phase 3 study of Bone Metastases, sponsored by M.D. Anderson Cancer Center.
NCT06065449 is a Phase 3 study of Bone Metastases that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 220 participants, above the 132-participant average among 10 other Bone Metastases trials with a reported enrollment target (67% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06065449, a Phase 3 study of Bone Metastases, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare increasing doses and different treatment schedules of stereotactic body radiation therapy (SBRT) against standard treatment scheduling.
Conditions Studied
Interventions
- DRUG Radiation Therapy
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2027-06-27 |
| Phase | Phase 3 |
What NCT06065449 shows while recruiting
NCT06065449 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, above the 132-participant average among 10 other Bone Metastases trials with a reported enrollment target (67% higher).
The record links to 1 condition, with Bone Metastases appearing as the primary indexed condition, and to 1 intervention - of which Radiation Therapy is the first listed.
NCT06065449 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06065449 about?
NCT06065449 is a clinical study titled "A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases". To compare increasing doses and different treatment schedules of stereotactic body radiation therapy (SBRT) against standard treatment scheduling.
What is the current status of trial NCT06065449?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 220 participants. The study started on 2024-01-24. Estimated completion is 2027-06-27.
What conditions does trial NCT06065449 study?
This clinical trial studies the following conditions: Bone Metastases.
What interventions are being tested in trial NCT06065449?
The interventions under investigation include: Radiation Therapy (DRUG).
Who is sponsoring clinical trial NCT06065449?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06065449 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06065449's enrollment target sits among peer trials
220 4th of 10 higher than 7 of 10 other Bone Metastases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bone Metastases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Registry for Bone Metastases
RECRUITING
-
Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
RECRUITING · NA
-
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
-
FDG PET/CT in Breast Cancer Bone Mets
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI